Geron | GERN - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Amgen USD 541M 1000K 2026-06
Bio Techne USD 156.45M 703K 2026-03
Cassava Sciences USD 48.31M 0 2026-03
Cytokinetics USD 124.43M 2.17M 2026-03
Exelixis USD 248.88M 4.82M 2026-06
Genmab DKK 61.44M 181K 2026-06
Geron USD 640.9M 2.54M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
Incyte USD 200.98M 1.03M 2026-06
MacroGenics USD 63.56M 241K 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novavax USD 162.58M 106K 2025-12